← FDA DRUG APPROVALS

FDA ANDA · ANDA065392

CEFADROXIL

Sponsor: LUPIN

APPLICATION
ANDA065392
TYPE
ANDA
ORIGINAL APPROVAL
2007-05-29
LATEST ACTION
2007-12-13
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

CEFADROXILPrescription
CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 500MG BASE · CAPSULE · ORAL

Approval history

2007-12-13Labeling · Supplement 1AP
2007-05-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →